Crosspoint Capital Strategies’s Illumina ILMN Stock Holding History

Crosspoint Capital Strategies’s Portfolio ILMN Stock Details ILMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-36	Closed	-$6K	–	457
2015 Q4	$6K	Buy	+36	New	+$5.81K	﹤0.01%	776
2015 Q3	–	Sell	-1,227	Closed	-$261K	–	821
2015 Q2	$261K	Buy	+1,227	New	+$240K	0.07%	146
2015 Q1	–	Sell	-614	Closed	-$110K	–	618
2014 Q4	$110K	Buy	+614	New	+$108K	0.04%	274
2014 Q3	–	Sell	-25,938	Closed	-$4.19M	–	505
2014 Q2	$4.19M	Buy	25,938 +25,885	+48,840%	+$3.86M	1.58%	29
2014 Q1	$8K	Sell	53 -34,413	-100%	-$5.06M	﹤0.01%	498
2013 Q4	$6M	Buy	+34,466	New	+$3.16M	2%	22

Other funds holding ILMN

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Crosspoint Capital Strategies's ILMN Position: Q1 2016 in Review

Crosspoint Capital Strategies sold out of Illumina (ILMN) in Q1 2016, closing a stake of 36 shares — an estimated $6K sold.

Crosspoint Capital Strategies first reported a position in ILMN in Q4 2013 and held it in 6 quarters. The position peaked at $6M in Q4 2013. 552 funds tracked by Wall St. Rank hold ILMN as of Q1 2016.

Crosspoint Capital Strategies reported no remaining Illumina position as of Q1 2016 after selling out during the quarter.
Crosspoint Capital Strategies sold 36 Illumina shares in Q1 2016, an estimated $6K.
Crosspoint Capital Strategies first reported a position in Illumina in Q4 2013 and held it in 6 quarters.
Crosspoint Capital Strategies's Illumina position peaked at $6M in Q4 2013.
552 funds tracked by Wall St. Rank held Illumina as of Q1 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2016, filed 16 May 2016.